Spectral Diagnostics (EDTXF) 0.9100 $EDTXF Spectral

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Spectral Diagnostics (EDTXF) 0.9100 $EDTXF

Spectral Medical Announces Completion of Enrolment for Its Pivotal EUPHRATES Clinical Trial
Marketwired - Mon Jun 20, 7:02AM CDT
Company expects to announce primary clinical outcome results by end of September
EDT.TO: 1.20 (-0.01)

Spectral Medical Announces Acceptance of Pre-Clinical PMA Module for Toraymyxin(TM) by FDA
Marketwired - Thu Jun 16, 7:02AM CDT
Company remains on track and anticipates final submission in Q4 2016
EDT.TO: 1.20 (-0.01)

Spectral Announces Voting Results of Annual Meeting
Marketwire Canada - Wed Jun 01, 9:12AM CDT
TORONTO, ONTARIO--(Marketwired - Jun 1, 2016) - Spectral Medical Inc. ("Spectral" or the "Company" (TSX:EDT) (OTCQX:EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced that at the annual meeting (the "Meeting" of shareholders of the Corporation ("Shareholders" that was held yesterday, all six nominees for the board were elected, the voting results of which are as follows:
EDT.TO: 1.20 (-0.01)

Spectral Medical Files Expanded Access Protocol With FDA for Toraymyxin(TM) Septic Shock Treatment
Marketwired - Tue May 31, 7:01AM CDT
Four patients remaining to enroll in the EUPHRATES clinical trial
EDT.TO: 1.20 (-0.01)

Spectral Announces First Quarter Results
Marketwired - Thu May 12, 7:02AM CDT
TORONTO, ONTARIO--(Marketwired - May 12, 2016) - Spectral Medical Inc., (TSX:EDT) (OTCQX:EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its unaudited financial results for the first quarter ended March 31, 2016.
EDT.TO: 1.20 (-0.01)

CORRECTION FROM SOURCE: Spectral Announces Fourth Quarter and Fiscal 2015 Results
Marketwired - Wed Mar 30, 11:49AM CDT
This document corrects and replaces the press release that was sent today at 8:00 a.m. The error occured in the 4th Paragraph in Financial Review where $14,048 should be $14,048,000. The complete and corrected version follows.
EDT.TO: 1.20 (-0.01)

Spectral Announces Fourth Quarter and Fiscal 2015 Results
Marketwired - Wed Mar 30, 7:02AM CDT
Spectral Medical Inc., (TSX: EDT) (OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its financial results for the fourth quarter and for the year ended December 31, 2015.
EDT.TO: 1.20 (-0.01)

Spectral Commends Inclusion of Organ Dysfunction in New Expert Consensus Definitions of Sepsis and Septic Shock
Marketwire Canada - Mon Mar 07, 6:00AM CST
Spectral Medical Inc. ("Spectral" or the "Company", (TSX:EDT) (OTCQX:EDTXF) a Phase III company advancing a precision treatment targeting specific patients at high risk of death from septic shock, today commented on the potential life-saving ramifications of the recently announced Third International Consensus Definitions for Sepsis and Septic Shock. Specifically, Spectral cites the definitions' new emphasis on organ dysfunction as a major contributor to the underlying pathology of sepsis and the main cause of death from septic shock. The updated definitions were issued on Feb. 23rd by a joint task force convened by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine and published online by the Journal of the American Medical Association(1).
EDT.TO: 1.20 (-0.01)

Spectral Medical Provides Clinical and Regulatory Update
Marketwired - Mon Jan 11, 8:41AM CST
Spectral Medical Inc., ("Spectral" or the "Company" (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with endotoxemic septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced that it is now recruiting the last 46 patients into its pivotal Phase III EUPHRATES trial. Based on current enrolment rates, it is expected that the trial should be completed in the first half of 2016.
EDT.TO: 1.20 (-0.01)

Spectral Announces Third Quarter 2015 Results
Marketwire Canada - Fri Nov 13, 7:00AM CST
Spectral Medical Inc., (TSX:EDT)(OTCQX:EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced its unaudited financial results for the third quarter ended September 30, 2015.
EDT.TO: 1.20 (-0.01)

Spectral Files Third Module of Rolling PMA Submission to FDA
Marketwire Canada - Thu Nov 12, 7:00AM CST
Spectral Medical Inc., ("Spectral" or the "Company" (TSX:EDT) (OTCQX:EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced that it has filed the third of four required Pre-Market Approval ("PMA"modules to the FDA. This module details the manufacturing processes for the Toraymyxin(TM) ("PMX" hemoperfusion cartridge. Spectral is in the later stages of a Phase III registration trial for PMX as it seeks FDA approval for this medical device in the United States. The fourth PMA module, related to clinical data, is expected to be filed by no later than the last quarter of 2016 as a final step towards anticipated FDA approval.
EDT.TO: 1.20 (-0.01)

Spectral Announces European Distribution Agreement With Fresenius Medical Care for Its Endotoxin Activity Assay (EAA(TM)) Diagnostic
Marketwired - Tue Nov 10, 7:04AM CST
Spectral Medical Inc., ("Spectral" or the "Company" (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a therapeutic device guided by a companion diagnostic, today announced that it has entered into a non-exclusive agreement with Fresenius Medical Care Deutschland GmbH to distribute Spectral's FDA approved rapid test for the assessment of endotoxin activity in human whole blood (EAA(TM)) in eight European countries - Germany, Denmark, Sweden, Finland, Norway, Poland, Hungary and the Czech Republic. It is expected that the EAA(TM) will initially be sold in conjunction with the Toraymyxin(TM) ("PMX" hemoperfusion cartridge, a medical device which removes endotoxin from the bloodstream, to guide patient treatment. Spectral is now in the final stages of its Phase III registration trial in anticipation of FDA approval for PMX in the United States.
EDT.TO: 1.20 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 151

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 109

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Radiotherapy Suit Challenges New EviCore Guidelines

Updated Category News Views 43

Turning Up the Heat on EviCore Winter Park, Florida—home of sunshine, oranges, and now a heated legal standoff. On November 16, 2026, the Radiotherapy Access Alliance dropped a bombshell lawsuit against EviCore over its recent guideline flip-flop. EviCore reversed its stance on low-dose radiation therapy (LDRT) for arthritis and other pesky pain, leaving patients—and...

Continue Reading
DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 16

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 21

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading
Flexible Packaging Market to Hit $384.32B by 2031

Updated Category News Views 17

Packaging's Flexible Future Alright, here's the skinny: you might want to adjust those portfolios if you're watching the materials sector, because the flexible packaging market ain't just loosening up—it's stretching out like never before. By 2031, we're talking about it raking in a solid $384.32 billion, climbing from $313.25 billion in 2026. That's a not-so-shabby...

Continue Reading
VIO Med Spa’s Black Friday Event: Aesthetic Savings

Updated Category News Views 34

Kicking Off the Holiday Season with a Glow Just when you think the holiday hustle can't get busier, VIO Med Spa is opening the gates of rejuvenation just in time to add yourself to that epic list. Starting November 16, VIO launches its Black Friday extravaganza—a deal-laden kick-off that means smooth skin and sharper looks are up for grabs. Member Benefits and Public...

Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future

Updated Category News Views 24

Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 49

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 362

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating a Milestone: Gifting the 400th Home to a Veteran

Updated Category News Views 339

Celebrating a Milestone with 400th Home Gift Building Homes for Heroes and Hillwood Properties proudly partnered to celebrate a significant milestone by gifting a home to U.S. Army Specialist Joshua Sager and his family. This remarkable achievement signifies the organization’s commitment to providing veterans and first responders with the means to establish a fresh...

Continue Reading
Wheeler REIT Achieves Record Price as Growth Continues

Updated Category News Views 259

Wheeler REIT Reaches New Milestone In an extraordinary demonstration of resilience and upward momentum, Wheeler Real Estate Investment Trust (WHLRD) has achieved a remarkable milestone by hitting a 52-week high of $27.49 USD. This achievement reflects the company's strong performance and investor confidence in its strategic direction. Strong Financial Position Recent data...

Continue Reading
S&P Global Splits Off Mobility Unit: Investor View

Updated Category News Views 52

Strategic Moves Shake Up S&P Global Listen up, traders! You don’t want to miss what S&P Global, ticker NYSE:SPGI, is cooking up. They've given the green light to split off their Mobility division, officially birthing Mobility Global Inc. This shake-up promises to stir some excitement in the market. Buckle up, because here's what this movement means for you and your...

Continue Reading
Carvana's Q3 Earnings Surge Promises Bright Future for CVNA

Updated Category News Views 103

Carvana Shares Soar After Impressive Q3 Earnings Report Recently, Carvana (NYSE: CVNA), a leading online used-car retailer, experienced a significant surge in its stock price as a result of a positive earnings announcement for the third quarter. The encouraging outlook provided by the company has delighted investors, pushing shares upward during premarket trading....

Continue Reading
PHINIA Unveils Comprehensive Guide to International Emission Standards

Updated Category News Views 150

PHINIA Unveils New Emission Standards Guide for 2024/25 PHINIA Inc. (NYSE: PHIN), a leading name in premium fuel systems and electrical solutions, has launched its latest 2024/25 Emission Standards Booklet specifically designed for heavy-duty and off-road vehicles, engines, and machinery. This guide is unique as it serves as the only complete resource available to keep...

Continue Reading